OpenAI Files for IPO, Targeting September 2026 Market Debut

OpenAI, the company behind ChatGPT and last valued at $852 billion, could be days away from submitting a confidential IPO registration to the Securities and Exchange Commission (SEC). The filing would set in motion what is positioned to become one of the most significant technology listings in a generation. With Goldman Sachs and Morgan Stanley leading the effort and a potential market debut targeted as early as September 2026, the window for investors to understand what is coming, and what remains unresolved, is now. What follows covers the mechanics of the confidential filing process, where OpenAI’s financials stand, the risks still hanging over the offering, and the specific disclosures retail investors should track as the process unfolds.

Goldman Sachs and Morgan Stanley are guiding OpenAI toward a September 2026 market debut

OpenAI is preparing to submit a draft S-1 registration statement confidentially to the SEC, with the filing potentially occurring within days, according to the Wall Street Journal, citing people with knowledge of the situation. Goldman Sachs and Morgan Stanley are the named lead underwriters assisting in drafting the registration documents.

The earliest targeted public market debut is September 2026, though the timeline remains subject to revision based on SEC review cycles and prevailing market conditions. The involvement of two bulge-bracket banks and a specific calendar target signal that this process has crossed from speculation into active preparation.

The three facts investors should anchor to:

• Filing window: Confidential S-1 submission expected as soon as the week of 20 May 2026
• Lead banks: Goldman Sachs and Morgan Stanley
• Earliest debut target: September 2026, contingent on SEC review and market conditions

What a confidential IPO filing actually means, and when investors will see the details

A confidential IPO filing is not secrecy for its own sake. Under SEC rules, companies planning public offerings may submit draft registration materials (an S-1 or draft registration statement) without immediate public disclosure. The mechanism allows issuers to work through SEC staff feedback, correct potential disclosure errors, and resolve ambiguities before the document faces public scrutiny.

The process follows a structured sequence:

1. Confidential submission: The company files its draft S-1 with the SEC. This document is not visible to the public or retail investors.
2. SEC review: Staff review the filing and may request amendments or additional disclosure, a process that can involve multiple rounds.
3. Public S-1 release: The draft S-1 must become publicly available at least 15 days before the company begins its roadshow or publicly announces the offering.
4. Roadshow: Company management presents to institutional investors.
5. Pricing: The final offering price is set.
6. Market debut: Shares begin trading on a public exchange.

The 15-day rule is the single most important milestone for retail investors. Until the public S-1 is released, no audited financials, risk factor disclosures, or management discussion will be available outside OpenAI’s private investor base.

The skills required for reading an S-1 prospectus extend beyond the headline financials: the management discussion and analysis section, the risk factors hierarchy, and the use-of-proceeds disclosure each reward close reading in ways that summary coverage rarely captures.

The typical timeline from confidential filing to market debut spans several weeks to a few months, depending on the depth of SEC review and the number of required amendments.

A $852 billion private valuation and $2 billion a month in revenue, but profitability is still an open question

The growth numbers are difficult to dismiss. OpenAI closed its $122 billion Series C funding round on 31 March 2026, the largest private funding round on record, establishing a post-money valuation of $852 billion. Revenue has followed a steep trajectory, with the company generating approximately $3.7 billion in full-year 2024, roughly $6 billion in 2025, and reaching a $24-25 billion annualised run rate by early 2026.

OpenAI is currently generating $2 billion in monthly revenue, driven by ChatGPT subscriptions, API usage, and accelerating enterprise adoption.

Enterprise revenue now exceeds 40% of total revenue and is projected to approach parity with consumer revenue by the end of 2026. That shift matters: enterprise contracts tend to carry longer duration and higher retention than consumer subscriptions, which strengthens the recurring revenue argument.

Then there is the cost side. Despite this revenue trajectory, losses remain material. OpenAI’s infrastructure and compute spending, including ongoing data centre buildout, continues to outpace revenue growth in absolute terms. The S-1 will need to address the path to profitability directly, and the valuation multiple implied by an $852 billion private figure against $24-25 billion in annualised revenue leaves limited room for that answer to be vague.

Two unresolved risks that could shape the IPO’s timing and reception

Neither of the risks below is necessarily a deal-breaker. Both, however, will appear in the S-1’s risk factors section, and both will surface during roadshow questioning. Knowing what to look for in those disclosures gives investors a measurable advantage in evaluating the offering.

Musk litigation: reduced threat, but not resolved

A federal jury dismissed Elon Musk’s lawsuit against OpenAI on 18 May 2026 on statute-of-limitations grounds. The immediate legal threat has diminished. Musk, however, announced plans to appeal the verdict to the 9th Circuit, which means the litigation remains a live disclosure item in any registration statement.

• The appeal ensures the case must be addressed in the S-1’s risk factors, adding disclosure complexity
• Ongoing media coverage of the appeal could complicate investor messaging during the roadshow period
• Legal analysts have characterised the suit as a headline and distraction risk rather than a structural IPO blocker, absent injunctive relief or a major settlement complication

The jury dismissal removed the most acute scenario, an injunction that could have delayed or blocked the offering. The appeal keeps the matter on the disclosure ledger.

Anthropic’s enterprise push: a valuation pressure point

Anthropic has emerged as the most significant near-term enterprise AI challenger to OpenAI, with particular strength in business-to-business adoption, developer traction, and model quality perception among technical buyers. Analyst commentary in recent months has framed Anthropic as outpacing OpenAI in certain enterprise adoption metrics.

• Anthropic’s competitive pressure narrows OpenAI’s pricing power in API and enterprise contracts, complicating the growth narrative at an $852 billion valuation
• The IPO roadshow will need to address why OpenAI’s enterprise moat is durable, not just growing
• If Anthropic continues to gain enterprise share, it creates a credible counter-narrative that institutional investors will weigh against OpenAI’s revenue multiple

At a valuation that already requires significant multiple expansion to justify, the competitive landscape makes the enterprise revenue breakdown in the S-1 one of the most closely watched sections of the document.

What retail investors should actually watch for as OpenAI moves toward public markets

The public S-1 release is the single most important event for retail investors. Until that document is available, audited financials, a detailed management discussion, and the full risk factors section remain inaccessible. The 15-day minimum window between the public S-1 release and the roadshow is the preparation window investors should plan around.

The specific disclosures and signals worth tracking, in order of priority:

1. Confirmed IPO valuation range: No specific range has been disclosed publicly as of 20 May 2026. The S-1 and subsequent amendments will establish whether the offering prices above, at, or below the $852 billion private mark.
2. Profitability timeline guidance: The management discussion section should address when OpenAI expects infrastructure spending to be outpaced by revenue, or whether profitability remains an open-ended investment.
3. Musk litigation treatment in risk factors: The language used to characterise the appeal, and any potential financial exposure, will signal how seriously the company and its counsel view the remaining legal risk.
4. Enterprise revenue breakdown: A detailed split between consumer and enterprise revenue, including contract duration and retention data, will determine how investors model recurring revenue durability.
5. Roadshow date announcement: Once a roadshow date is set, the pricing and debut timeline compress rapidly. This is the signal that the offering has moved from preparation to execution.

September 2026 is the earliest potential debut, not a guaranteed date. Investors should treat the confidential filing as the start of a structured process rather than the beginning of a countdown.

Investors exploring the broader market environment into which OpenAI would debut will find our full explainer on tech sector valuation conditions, which covers sell-side forecast overextension, record institutional overweight positioning in US technology, and the compounding effect of simultaneous large-cap listings on available capital in the IPO market.

One of tech’s biggest listings is taking shape, but the real information is still coming

OpenAI’s confidential filing marks the formal beginning of a structured SEC process, not the finish line. What investors now know: the filing mechanism is a standard regulatory pathway with a specific public disclosure trigger, the revenue trajectory is steep but the cost structure remains unresolved, and two live risks (the Musk appeal and Anthropic’s enterprise momentum) will shape both the S-1’s disclosures and the roadshow’s reception.

The material information, audited financials, a confirmed valuation range, and management’s profitability guidance, arrives when the public S-1 is released. That document, not the confidential filing itself, is the moment to watch.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Forward-looking statements regarding OpenAI’s IPO timeline, valuation, and financial performance are subject to change based on market developments, regulatory review, and company decisions.